ABL

Abbott Laboratories · BSESOF:ABL

94.78 EUR1.72 +1.85%

Abbott Laboratories (BSESOF:ABL) last traded at 94.78 EUR, up 1.85% on the day. Over the past year the stock is down 12.27%. Its 52-week range is 71.20 to 113.46. It is in the Health Technology sector (Medical Specialties).

Key statistics

Open94.78

Day range94.78 – 94.78

52-week range71.20 – 113.46

Volume0

Average volume (10 days)0

Market cap (USD)183.77 B

P/E39.64

EPS (TTM) (USD)2.71

Dividend yield2.34%

Beta (1 year)−0.4600

Revenue (TTM) (USD)48.23 B

Employees115.00 K

Performance

+3.07%1 week

+8.47%1 month

+4.20%3 months

+22.33%6 months

−9.99%Year to date

−12.27%1 year

Technical reading

Strongly bullish

Daily summary of what 11 oscillators and 15 moving averages show. See every indicator

Latest headlines

Notable analyst calls this week: Broadcom, Moderna and Abbott among top picksSeeking Alpha · 31 Oct 2026
HHS proposes changes to infant formula standardsSeeking Alpha · 29 Oct 2026
Abbott Initiates Pivotal Trial For Cephea™ Device, An Innovative Treatment For Mitral Heart Valve DiseaseReuters · 29 Oct 2026
Abbott Receives FDA Approval For First Device To Treat Leaks After Heart Valve ReplacementReuters · 28 Oct 2026
Abbott downgraded at Argus on guidance cutSeeking Alpha · 27 Oct 2026
Abbott Labs Cut to Hold From Buy by Argus ResearchDow Jones Newswires · 27 Oct 2026
Weekly Recap: Tighter EPS outlook and Exact Sciences in Cancer DiagnosticsTradingView · 26 Oct 2026
Abbott Labs Is Maintained at Overweight by Wells FargoDow Jones Newswires · 23 Oct 2026

Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.